## Abstract ## BACKGROUND. Angiotensin I‐converting enzyme (ACE) inhibitors, angiotensin II antagonists, and the ACE insertion/deletion (I/D) gene polymorphism all influence serum angiotensin II action. Because angiotensin II levels have been associated with cancer, the objective of the current ep
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and the risk for restenosis after PTCA
✍ Scribed by Henry Völzke; Sabine Hertwig; Rainer Rettig
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 706 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1061-1711
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
An insertion(I)/deletion(D) polymorphism in the angiotensin I-converting enzyme (ACE) gene seems to be associated with clinical heart disease in patients with diabetes mellitus. It is not known whether increased atherosclerosis or other factors among individuals with certain ACE-gene subtypes form t
A recent Japanese study on the angiotensin I converting enzyme gene (ACE) insertion/ deletion polymorphism reported that both the D allele (P < 0.02) and the DD genotype (P < 0.002) were significantly more frequent in affective disorder cases than in controls [Arinami et al., 1996: Biol Psychiatry 4